Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon Hudson

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Addiction (Abingdon, England)|April 9, 2024
Broad evidence of xylazine in the UK illicit drug market beyond heroin supplies: Triangulating from toxicology, drug-testing and law enforcementCaroline S Copeland, Kathleen Rice, Kirsten L Rock, et al.
Emergency Medicine Journal : EMJ|June 4, 2025
Nitazene detections and clinical characteristics: data from a prospective observational study in a Glasgow emergency departmentRufus Turner, Lisa Christine Dunlop, David John Lowe, et al.
Clinical Toxicology (Philadelphia, Pa.)|June 3, 2021
Detection of flubromazolam in patients with suspected non-medical drug use attending emergency departments in the United KingdomMark Haden, Josephine Cashman, Andrew Ketchin, et al.
Clinical Chemistry|March 10, 2022
Machine Learning to Assist in Large-Scale, Activity-Based Synthetic Cannabinoid Receptor Agonist Screening of Serum SamplesLiesl K Janssens, Dimitri Boeckaerts, Simon Hudson, et al.
Clinical Toxicology (Philadelphia, Pa.)|April 20, 2017
Analytical confirmation of synthetic cannabinoids in a cohort of 179 presentations with acute recreational drug toxicity to an Emergency Department in London, UK in the first half of 2015Rachelle Abouchedid, Simon Hudson, Natalie Thurtle, et al.
Clinical Toxicology (Philadelphia, Pa.)|February 8, 2026
Is nitazene-related mortality underestimated? Findings from an <i>in vivo</i> and <i>ex vivo</i> rat study and pharmacoepidemiological analysis of coroner-reported deathsShuoqi Chen, Daniyar Aldabergenov, Khalid S Alotaibi, et al.
Clinical Toxicology (Philadelphia, Pa.)|November 2, 2022
Accuracy of substance exposure history in patients attending emergency departments after substance misuse; a comparison with biological sample analysisIshita Virmani, Alberto Oteo, Michael Dunn, et al.
Frontiers in Public Health|December 22, 2025
Data science without borders: bridging the divide in data science capacity across African health institutionsAgnes N Kiragga, Samuel Iddi, Abel W Walekhwa, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Addiction (Abingdon, England)|April 9, 2024
Broad evidence of xylazine in the UK illicit drug market beyond heroin supplies: Triangulating from toxicology, drug-testing and law enforcementCaroline S Copeland, Kathleen Rice, Kirsten L Rock, et al.
Emergency Medicine Journal : EMJ|June 4, 2025
Nitazene detections and clinical characteristics: data from a prospective observational study in a Glasgow emergency departmentRufus Turner, Lisa Christine Dunlop, David John Lowe, et al.
Clinical Toxicology (Philadelphia, Pa.)|June 3, 2021
Detection of flubromazolam in patients with suspected non-medical drug use attending emergency departments in the United KingdomMark Haden, Josephine Cashman, Andrew Ketchin, et al.
Clinical Chemistry|March 10, 2022
Machine Learning to Assist in Large-Scale, Activity-Based Synthetic Cannabinoid Receptor Agonist Screening of Serum SamplesLiesl K Janssens, Dimitri Boeckaerts, Simon Hudson, et al.
Clinical Toxicology (Philadelphia, Pa.)|April 20, 2017
Analytical confirmation of synthetic cannabinoids in a cohort of 179 presentations with acute recreational drug toxicity to an Emergency Department in London, UK in the first half of 2015Rachelle Abouchedid, Simon Hudson, Natalie Thurtle, et al.
Clinical Toxicology (Philadelphia, Pa.)|February 8, 2026
Is nitazene-related mortality underestimated? Findings from an <i>in vivo</i> and <i>ex vivo</i> rat study and pharmacoepidemiological analysis of coroner-reported deathsShuoqi Chen, Daniyar Aldabergenov, Khalid S Alotaibi, et al.
Clinical Toxicology (Philadelphia, Pa.)|November 2, 2022
Accuracy of substance exposure history in patients attending emergency departments after substance misuse; a comparison with biological sample analysisIshita Virmani, Alberto Oteo, Michael Dunn, et al.
Frontiers in Public Health|December 22, 2025
Data science without borders: bridging the divide in data science capacity across African health institutionsAgnes N Kiragga, Samuel Iddi, Abel W Walekhwa, et al.
Pageof 4